US EditionPublished • loading... • Updated
TrumpRx lists many medicines at prices higher than paid in UK
Reuters found one-third of 54 drugs on TrumpRx.gov were cheaper in the UK, highlighting pricing differences despite the most-favored-nation deals with 16 drugmakers.
- A Reuters comparison published March 18 found TrumpRx.gov does not deliver lower prices than in the United Kingdom, according to Reuters reporters Bhanvi Satija and Michael Erman.
- U.S. President Donald Trump designed the program to reduce prescription drug costs, launching the TrumpRx website in January as part of deals with 16 drugmakers; Reuters found it does not always offer lower prices than the UK.
- Data show that around a third of the 54 drugs listed on TrumpRx were lower priced in the UK, while TrumpRx reflects American cash-paying consumers, not insured rates.
- The industry said negotiated prices could impact sales, with Novo warning profit could drop as much as 13% in 2026, while TrumpRx lists an 84% discount on three U.S. fertility drugs.
- The international context matters because The United Kingdom struck a deal to avoid U.S. drug tariffs in exchange for spending more on medicines, while analysts cited by Reuters said J&J's $60 billion sales last year make revenue hits small.
Insights by Ground AI
5 Articles
5 Articles
Coverage Details
Total News Sources5
Leaning Left1Leaning Right1Center3Last UpdatedBias Distribution60% Center
Bias Distribution
- 60% of the sources are Center
60% Center
L 20%
C 60%
R 20%
Factuality
To view factuality data please Upgrade to Premium
